GlassScriptPhysician profile
Steven Morse
NPI 1225328941
$697.25
in general payments reported to CMS, 2019-2025
21 companies · $60.33 in 2025
The $60.33 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $275 · 2020: $75.30 · 2021: $103 · 2022: $148 · 2023: $35.64 · 2025: $60.33.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $95.97.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $95.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $104.41 | 2019-2022 | |
| Roche Diagnostics Corporation | $65.17 | 2019-2020 | |
| Duchesnay USA Incorporated | $64.58 | 2019 | |
| Baxter Healthcare | $58.82 | 2019-2025 | Perclot |
| Applied Medical Resources Corporation | $40.29 | 2022 | |
| Amag Pharmaceuticals, INC. | $38.05 | 2019-2020 | |
| Aspira Women'S Health INC | $36.45 | 2019 | |
| Organon LLC | $30.90 | 2021-2022 | |
| Coopersurgical, INC. | $30.84 | 2019-2022 | |
| Exeltis, USA INC. | $26.97 | 2020-2022 | |
| Pfizer INC. | $23.32 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.34 | 2021 | |
| Evofem Biosciences, INC. | $19.82 | 2021 | |
| Biogen, INC. | $19.73 | 2025 | Zurzuvae |
| Lupin INC. | $19.02 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $18.92 | 2021 | |
| Mayne Pharma Commercial LLC | $18.28 | 2023 | |
| Agile Therapeutics, INC. | $17.36 | 2023 | Twirla |
| Ethicon US, LLC | $17.24 | 2022 | |
| Mission Pharmacal Company | $15.14 | 2019 | |
| Abbvie INC. | $11.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Morse listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.